| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |